If we take a look at MSD’s international presence, the group has grown into the third largest pharma company in the world. Here in South Africa,…
In Conversation
Focus Reports is back in South Africa as part of a second set of reports on the BRICS. What would you say are the main changes…
South Africa is at the moment one of the world’s most exciting and dynamic markets at the moment as Mr. Omar Ehsan was telling us, the…
Could you introduce to our readers MC Pharma’s business model in the South African market as well as the main milestones in the company’s development over…
Mr. Daniel, after working with Pfizer Australia, working in Hong Kong as Regional Marketing Director for the Asian operation and in Japan, you have been the…
The line between research based pharmaceutical companies and generic companies is today less and less relevant, as we have seen in the past few years generic…
Mr. Godard, you previously worked in Europe for Baxter Edwards Life Sciences, what made you decide to move to South Africa in a smaller company? It…
Your professional career went back and forth between creating your own business and running a smaller and very dynamic structure and managing over a thousand of…
You were recently appointed at the head of Eli Lilly South African operations. What is the specific mission you have been given? Eli Lilly South Africa…
Since we interviewed you in 2005, there have been many changes in the market, from consolidation, an increasing generic penetration, to new healthcare reforms… How have…
Ms Joubert, could you start by telling our readers over the 16 months of heading the operations here, what have been the most challenging situations as…
We interviewed Graham Somerville in 2004, the year when IHD, formerly jointly owned by 11 major pharmaceutical companies, was acquired by UTi. We are interviewing you…
